Tim Eisen
Impact in
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 20
- Lung Cancer Treatments and Mutations 3
-
- Cancer Genomics and Diagnostics 10
- Co-authors
- Bernard Escudier (5 shared papers)Peter F.A. Mulders (2 shared papers)Lucy Gossage (1 shared paper)Cora N. Sternberg (7 shared papers)Vesa Kataja (1 shared paper)Vincent Khoo (1 shared paper)J.-J. Patard (1 shared paper)Ferrán Algaba (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Annals of Oncology (5 papers)European Journal of Cancer (2 papers)Expert Opinion on Investigational Drugs (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomItalyNetherlands
In The Last Decade
Tim Eisen
28 papers receiving 928 citations
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 565
- Cancer Research 235
- Oncology 230
- Molecular Biology 368
- Immunology 59
Countries citing papers authored by Tim Eisen
This map shows the geographic impact of Tim Eisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Eisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Eisen more than expected).
Fields of papers citing papers by Tim Eisen
This network shows the impact of papers produced by Tim Eisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Eisen. The network helps show where Tim Eisen may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Eisen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 237 | |
| 2 | 2012 | 170 | |
| 3 | 2010 | 97 | |
| 4 | 2012 | 71 | |
| 5 | 2018 | 64 | |
| 6 | 2018 | 54 | |
| 7 | 2018 | 35 | |
| 8 | 2015 | 32 | |
| 9 | 2013 | 21 | |
| 10 | 2019 | 21 | |
| 11 | 2015 | 18 | |
| 12 | 2014 | 17 | |
| 13 | 2000 | 14 | |
| 14 | 2019 | 14 | |
| 15 | 2012 | 14 | |
| 16 | 2011 | 12 | |
| 17 | 2010 | 9 | |
| 18 | 2013 | 8 | |
| 19 | 2009 | 6 | |
| 20 | 2021 | 5 |
About Tim Eisen
Tim Eisen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Oncology and Economics and Econometrics, having authored 30 papers that have together received 940 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (20 papers), Cancer Genomics and Diagnostics (10 papers), Renal and related cancers (7 papers), Economic and Financial Impacts of Cancer (4 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (565 citations), Cancer Research (235 citations), Oncology (230 citations), Molecular Biology (368 citations) and Immunology (59 citations). Tim Eisen has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Bernard Escudier, Peter F.A. Mulders, Lucy Gossage, Cora N. Sternberg, Vesa Kataja, Vincent Khoo, J.-J. Patard, Ferrán Algaba, Camillo Porta and L Pyle. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Expert Opinion on Investigational Drugs and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.